Steve Brozak

Stock Analyst at WBB Securities

(0)
# 5304
Out of 5,333 analysts
13
Total ratings
0.00%
Success rate
-80.49%
Average return
7 Stocks
Name Action PT Current % Upside Ratings Updated
MRKR Marker Therapeutics
Reiterates: Strong Buy
13 13
1.27 884.25% 1 Apr 1, 2025
CFRX ContraFect
Upgrades: Strong Buy
560
n/a n/a 3 Jun 8, 2022
PRTK Paratek Pharmaceutic...
Upgrades: Strong Buy
11
n/a n/a 2 Feb 10, 2022
CDTX Cidara Therapeutics
Upgrades: Strong Buy
n/a
n/a n/a 1 Sep 22, 2021
CWBR CohBar
Upgrades: Buy
150
n/a n/a 2 Aug 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
75 100
6.31 1484.79% 1 Jun 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Buy
17000 16000
2.02 791979.21% 3 May 28, 2021